H.R.1082

Shandra Eisenga Human Cell and Tissue Product Safety Act

Chamber Passed·6/24/25

The Shandra Eisenga Human Cell and Tissue Product Safety Act mandates education campaigns and updates on human cell and tissue products.

The Shandra Eisenga Human Cell and Tissue Product Safety Act requires the Secretary of Health and Human Services to conduct a national, evidence-based education campaign to increase public and health care provider awareness regarding the potential risks and benefits of human cell and tissue products transplants. The act also mandates updates on scientific and regulatory aspects of human cell and tissue products, including the establishment of a public docket for stakeholder comments.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Last
Passed the House · Jun 24, 2025
Current
Health, Education, Labor, And Pensions Committee
Next
Senate floor vote

Sponsors

1
1
Democratic CaucusRepublican Caucus

History

Jun 24, 2025

Senate

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Jun 23, 2025

House

Mr. Bilirakis moved to suspend the rules and pass the bill.

Jun 23, 2025

House

Considered under suspension of the rules. (consideration: CR H2860-2862)